Evotec SE (FRA:EVT)
Germany · Delayed Price · Currency is EUR 6.32
+0.00 (0.06%)
At close: Jan 9, 2026
Evotec SE Revenue
In the year 2024, Evotec SE had annual revenue of 796.97M EUR with 1.99% growth. Evotec SE had revenue of 163.89M in the quarter ending September 30, 2025, a decrease of -5.75%.
Revenue
796.97M
Revenue Growth
+22.68%
P/S Ratio
1.47
Revenue / Employee
157.96K
Employees
4,740
Market Cap
1.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 796.97M | 15.54M | 1.99% |
| Dec 31, 2023 | 781.43M | 29.98M | 3.99% |
| Dec 31, 2022 | 751.45M | 133.41M | 21.59% |
| Dec 31, 2021 | 618.03M | 117.11M | 23.38% |
| Dec 31, 2020 | 500.92M | 54.49M | 12.20% |
| Dec 31, 2019 | 446.44M | 71.03M | 18.92% |
| Dec 31, 2018 | 375.41M | 332.72M | 779.52% |
| Dec 31, 2009 | 42.68M | 3.07M | 7.75% |
| Dec 31, 2008 | 39.61M | 6.73M | 20.46% |
| Dec 31, 2007 | 32.89M | -7.69M | -18.95% |
| Dec 31, 2006 | 40.58M | -1.26M | -3.02% |
| Dec 31, 2005 | 41.84M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Mercedes-Benz Group AG | 136.97B |
| Bayerische Motoren Werke Aktiengesellschaft | 136.42B |
| Deutsche Telekom AG | 121.02B |
| Allianz SE | 105.02B |
| Siemens Aktiengesellschaft | 78.91B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Siemens Energy AG | 39.08B |
| SAP SE | 36.49B |
Evotec SE News
- 3 days ago - Evotec SE (EVO) Secures Gates Foundation Grant for Biotherapeutics - GuruFocus
- 3 days ago - Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access - Accesswire
- 3 days ago - Evotec Secures Grant to Use AI for Cost-Effective Monoclonal Antibody Development - Wallstreet:Online
- 3 days ago - EQS-News: Just – Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access - Wallstreet:Online
- 9 days ago - Evotec SE: Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations - Finanz Nachrichten
- 9 days ago - Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations - Accesswire
- 10 days ago - Evotec Names Dr. Sarah Fakih as New EVP of Global Communications & IR - Wallstreet:Online
- 10 days ago - EQS-News: Evotec appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations - Wallstreet:Online